Table 1

Prevalence of hepatitis C antibodies and estimated population ever-infected in a representative sample of individuals living in the state capitals of Brazil, 2005–2009
Setting age-group Participants Prevalence* % (95% CI) State capitals population Estimated persons ever infected n (95% CI)
Brazil
 10 – 19 9,371 0.75 (0.53 – 0.98)† 7,565,695 56,970 (39,947 – 74,068)
 20 – 39 5,552 1.36 (1.02 – 1.71)† 13,828,140 188,478 (140,494 – 236,462)
 40 – 59 3,719 1.55 (1.09 – 2.01)† 7,941,985 122,783 (86,250 – 159,396)
 60 – 69 891 3.41 (2.03 – 4.79)† 1,916,570 65,432 (38,964 – 91,900)
North
 10 – 19 1,153 0.99 (0.36 –1.63) 860,922 8,601 (3,117 – 14,093)
 20 – 69 1,135 3.22 (2.02 – 4.41) 2,093,269 67,403 (42,472 – 92,334)
Northeast
 10 – 19 1,840 0.38 (0.10 – 0.66) 2,054,539 7,848 (2,096 – 13,601)
 20 – 69 1,850 0.97 (0.48 – 1.47) 5,358,923 52,249 (25,616 – 78,883)
Midwest
 10 – 19 1,803 0.99 (0.53 – 1.47) 866,536 8,657 (4,601 – 12,712)
 20 – 69 1,899 1.64 (1.14 – 2.13) 1,326,575 21,703 (15,110 – 28,296)
Federal District
 10 – 19 980 0.61 (0.13 – 1.09) 387,831 2,374 (524 – 4,227)
 20 – 69 1,008 1.09 (0.50 – 1.68) 1,202,183 13,116 (6,011 – 20,245)
Southeast
 10 – 19 1,794 0.90 (0.49 – 1.31) 3,295,110 29,755 (16,212 – 43,298)
 20 – 69 1,867 1.63 (1.07 – 2.18) 11,661,984 189,857 (124,783 – 254,814)
South
 10 – 19 1,801 0.51 (0.12 – 0.89) 586,270 2,978 (715 – 5,241)
 20 – 69 2,373 1.70 (1.08 – 2.32) 2,043,761 34,826 (22,175 – 47,456)

* Prevalence adjusted for random effect.

† Prevalence adjusted for random effect and weighted by regions.

Pereira et al.

Pereira et al. BMC Infectious Diseases 2013 13:60   doi:10.1186/1471-2334-13-60

Open Data